SEC Form 4 research
| Issuer | Dianthus Therapeutics, Inc. /DE/ |
|---|---|
| Tickers | DNTH, MGTA |
| Reporting owners | 57 |
| Officers and directors | 22 |
| Last public filing | 2026-09-18 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-18 | 2026-09-17 | CARR EDWARD | S | 700 | $104.39 | Not reported |
| 2026-09-18 | 2026-09-17 | CARR EDWARD | S | 1,100 | $103.2 | Not reported |
| 2026-09-18 | 2026-09-17 | CARR EDWARD | S | 3,501 | $102.39 | Not reported |
| 2026-09-18 | 2026-09-17 | CARR EDWARD | S | 6,771 | $101.37 | Not reported |
| 2026-09-18 | 2026-09-17 | CARR EDWARD | S | 7,928 | $100.43 | Not reported |
| 2026-09-03 | 2026-09-01 | Randhawa Simrat | S | 13,309 | $106.74 | Not reported |
| 2026-09-03 | 2026-09-01 | Randhawa Simrat | S | 7,215 | $106.25 | Not reported |
| 2026-09-03 | 2026-09-01 | Randhawa Simrat | S | 2,600 | $105.19 | Not reported |
| 2026-08-19 | 2026-08-19 | Read Simon | S | 2,778 | $117.55 | Not reported |
| 2026-08-11 | 2026-08-10 | McGeorge Anne | S | 700 | $111.41 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.